| Revolution Medicines, Inc. | 563K | US$105M | 20.1% |
| Stereotaxis, Inc. | 13.7M | US$23.5M | 4.5% |
| Nektar Therapeutics | 318K | US$22.2M | 4.2% |
| Denali Therapeutics Inc. | 739K | US$19M | 3.6% |
| Ideaya Biosciences, Inc. | 497K | US$18.5M | 3.5% |
| Atricure, Inc. | 597K | US$16.7M | 3.2% |
| Xenon Pharmaceuticals Inc. | 251K | US$15.1M | 2.9% |
| Cytokinetics, Incorporated | 172K | US$14.7M | 2.8% |
| Arcus Biosciences, Inc. | 442K | US$13.6M | 2.6% |
| Neurocrine Biosciences, Inc. | 57,769 | US$9.74M | 1.9% |
| Axogen, Inc. | 209K | US$9.65M | 1.8% |
| Insulet Corporation | 61,870 | US$9.42M | 1.8% |
| Edgewise Therapeutics, Inc. | 227K | US$9.22M | 1.8% |
| Bicara Therapeutics Inc. | 285K | US$8.46M | 1.6% |
| Syndax Pharmaceuticals, Inc. | 335K | US$7.33M | 1.4% |
| Maplight Therapeutics, Inc. | 171K | US$6.13M | 1.2% |
| Larimar Therapeutics, Inc. | 2.01M | US$6.12M | 1.2% |
| Century Therapeutics, Inc. | 2.4M | US$5.88M | 1.1% |
| Dexcom, Inc. | 86,279 | US$5.81M | 1.1% |
| Immunovant, Inc. | 150K | US$5.76M | 1.1% |
| Inogen, Inc | 845K | US$5.45M | 1.0% |
| Tandem Diabetes Care, Inc. | 355K | US$5.36M | 1.0% |
| Stoke Therapeutics, Inc. | 131K | US$4.28M | 0.82% |
| Allogene Therapeutics, Inc. | 2M | US$4.16M | 0.79% |
| Biocryst Pharmaceuticals, Inc. | 400K | US$4M | 0.76% |
| Lakefront Biotherapeutics | 130K | US$3.9M | 0.74% |
| Orthopediatrics Corp. | 189K | US$3.62M | 0.69% |
| Cybin, Inc. | 514K | US$3.4M | 0.65% |
| Rapport Therapeutics, Inc. | 75,000 | US$3.13M | 0.60% |
| Kymera Therapeutics, Inc. | 27,000 | US$3.1M | 0.59% |
| Neurogene Inc. | 89,032 | US$2.8M | 0.53% |
| Procept Biorobotics Corporation | 120K | US$2.71M | 0.52% |
| Aquestive Therapeutics, Inc. | 646K | US$2.69M | 0.51% |
| Celldex Therapeutics, Inc. | 68,518 | US$2.55M | 0.49% |
| Align Technology, Inc. | 14,000 | US$2.36M | 0.45% |
| Viking Therapeutics, Inc. | 59,516 | US$2.32M | 0.44% |
| Nervgen Pharma Corp. | 1.05M | US$2.16M | 0.41% |
| Biohaven Ltd. | 138K | US$2.05M | 0.39% |
| Maze Therapeutics, Inc. | 65,000 | US$1.94M | 0.37% |
| Alector, Inc. | 908K | US$1.83M | 0.35% |
| Lexeo Therapeutics, Inc. | 377K | US$1.76M | 0.33% |
| Profound Medical Corp | 260K | US$1.73M | 0.33% |
| Atrium Therapeutics, Inc. | 128K | US$1.72M | 0.33% |
| Annexon, Inc. | 298K | US$1.7M | 0.32% |
| Cytomx Therapeutics, Inc. | 438K | US$1.64M | 0.31% |
| Ultragenyx Pharmaceutical Inc. | 47,100 | US$1.57M | 0.30% |
| Eupraxia Pharmaceuticals, Inc. | 226K | US$1.49M | 0.28% |
| Design Therapeutics, Inc. | 103K | US$1.48M | 0.28% |
| Fate Therapeutics, Inc. | 525K | US$1.42M | 0.27% |
| Kura Oncology, Inc. | 121K | US$1.32M | 0.25% |
| Ars Pharmaceuticals, Inc. | 164K | US$1.32M | 0.25% |
| Mineralys Therapeutics, Inc. | 44,490 | US$1.2M | 0.23% |
| Tela Bio, Inc. | 1.44M | US$1.08M | 0.21% |
| Corbus Pharmaceuticals Holdings, Inc. | 108K | US$1.01M | 0.19% |
| Inspire Medical Systems, Inc. | 18,200 | US$812K | 0.15% |
| Adicet Bio, Inc. | 93,812 | US$811K | 0.15% |
| Seaport Therapeutics, Inc. | 32,400 | US$704K | 0.13% |
| Mbx Biosciences, Inc. | 11,809 | US$652K | 0.12% |
| Artiva Biotherapeutics, Inc. | 67,101 | US$651K | 0.12% |
| Pliant Therapeutics, Inc. | 487K | US$555K | 0.11% |
| Editas Medicine, Inc. | 170K | US$552K | 0.11% |
| Orchestra Biomed Holdings, Inc. | 127K | US$547K | 0.10% |
| Foghorn Therapeutics Inc. | 112K | US$546K | 0.10% |
| Accuray Incorporated | 1.68M | US$433K | 0.08% |
| Q32 Bio Inc. | 32,896 | US$419K | 0.08% |
| Nuvectis Pharma, Inc. | 20,000 | US$368K | 0.07% |
| Ibio, Inc. | 170K | US$298K | 0.06% |
| Tenaya Therapeutics, Inc. | 300K | US$222K | 0.04% |
| Verrica Pharmaceuticals Inc. | 23,750 | US$145K | 0.03% |
| Kardigan, Inc. | 5,000 | US$119K | 0.02% |
| Oric Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Scynexis, Inc. | 0 | US$0 | 0.00% |
| Zenas Biopharma, Inc. | 0 | US$0 | 0.00% |
| Ascendis Pharma A/s | 0 | US$0 | 0.00% |
| Engene Holdings Inc. | 0 | US$0 | 0.00% |
| Fulcrum Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Kalvista Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Karyopharm Therapeutics Inc. | 0 | US$0 | 0.00% |
| Neumora Therapeutics, Inc. | 0 | US$0 | 0.00% |